发明名称 Antibodies for determining the prothrombin fragment F2/F1+2 in a homogeneous immunoassay
摘要 The present invention is in the area of coagulation analysis and relates to antibodies which bind specifically to an immune complex of prothrombin fragment F2/F1+2 and an F2/F1+2 neoepitope-specific antibody fragment, and to the preparation and the use thereof in methods for determining F2/F1+2.
申请公布号 US9096674(B2) 申请公布日期 2015.08.04
申请号 US200912566464 申请日期 2009.09.24
申请人 Siemens Healthcare Diagnostics Products GmbH 发明人 Ehm Matthias;Fischer Bodo;Althaus Harald;Barten Roland;Teigelkamp Stefan
分类号 C07K16/36;C07K16/42;C12N5/20;C12P21/08;G01N33/563;G01N33/573;G01N33/86;C12N9/74 主分类号 C07K16/36
代理机构 Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P. 代理人 Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P.
主权项 1. An isolated immune complex comprising an antibody fragment and a peptide, wherein: the peptide includes at least a complete prothrombin fragment F2; the carboxy terminus of the complete prothrombin fragment F2 of the peptide is bound to the antibody fragment; the antibody fragment has specificity for a carboxy-terminal neoepitope of the prothrombin fragment F2 and/or fragment F1+2; and wherein the antibody fragment is a fragment of a monoclonal antibody made by hybridoma cell line DSM ACC 2911.
地址 Marburg DE